Molecular Pathways Regulating Airway Goblet Cell Mucin Secretion

调节气道杯状细胞粘蛋白分泌的分子途径

基本信息

  • 批准号:
    8049606
  • 负责人:
  • 金额:
    $ 49.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-04-01 至 2014-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The secreted gel-forming mucins of the airway provide important protective functions through the clearance of inhaled pathogens and particulates; however, mucin hypersecretion causes airflow obstruction and airway injury in most diseases of the airways. Therefore, tight control of mucin production and secretion is critical for airway homeostasis. Airway goblet cell mucin secretion is principally controlled by signaling pathways downstream of P2Y2 purinoceptors, though additional G-protein coupled receptors and receptor tyrosine kinases may also play significant roles. Activation of P2Y2 receptors by nucleotides in the airway liquid layer leads to generation of the second messengers diacylglyerol (DAG) and calcium (Ca2+) that together result in robust mucin secretion. Significantly, the majority of mucins secreted in a lung are released, continuously, at baseline, by pathways whose regulation is unknown. Components of the cellular exocytic machinery known to respond to agonist-generated second messengers are the Munc13 priming proteins that bind DAG and Ca2+, and the SNARE-triggering Synaptotagmin (Syt) proteins that bind phospholipids and Ca2+. We have found that the absence of one of the two Munc13 proteins expressed in the airways, Munc13-2, results in partial defects in baseline and stimulated mucin secretion in mice: this mouse model therefore offers the first experimental tool useful in unraveling regulated baseline mucin secretion. Munc13-4, the other isoform expressed, presumably regulates agonist stimulated mucin secretion; however, our preliminary data indicate it may play no role in baseline secretion. In contrast, the absence of Syt-2 results in a profound defect in stimulated secretion, but we deduce a paradoxical increase in baseline mucin secretion. Additional Syt isoforms are expressed in mouse and human mucous cells whose interactions with Syt-2 might explain these paradoxical results. We hypothesize that baseline and agonist stimulated mucin secretion is controlled by signaling pathways upstream of Munc13 and Syt proteins in airway mucin secreting cells, and that specific Munc13/Syt pairs partition baseline and agonist stimulated mucin secretions. Mouse models will be used to test this hypothesis and to determine the precise mechanisms of regulation of airway mucin secretion. In Specific Aim 1, we will determine the roles of Munc13-2 and Munc13-4 in airway mucin secretion in vivo and in vitro, and identify how they are regulated and how they contribute individually to baseline and agonist stimulated pathways. For Specific Aim 2, we will determine the roles of Syt-2 and Syt-7 in airway mucin secretion in vivo and in vitro, identify whether and how they are regulated to contribute differentially to baseline and agonist stimulated pathways, and determine whether there are significant functional interactions between the Syt and Munc13 isoforms of interest. PUBLIC HEALTH RELEVANCE: Mucin hypersecretion, resulting in a overproduction of mucus in the airways of the lungs, substantially increases patient morbidity and mortality in literally all the airways diseases, common ones (chronic bronchitis and asthma) and orphan ones (cystic fibrosis and primary ciliary dyskinesia) alike, irrespective of the initiating environmental and/or genetic insult. Consequently, it is important to understand the molecular pathways by which mucins are secreted and by which their secretion is regulated, to enable effective therapeutic design and treatment. This project will use gene knockout and overexpression mouse models to reveal the roles of two kinds of proteins involved in regulating mucin secretion, Munc13, which is responsible for priming the secretory apparatus, and synaptotagmin, which acts as the final intracellular calcium sensor and trigger of secretion.
描述(由申请人提供):气道的分泌凝胶形成的粘液通过清除吸入的病原体和颗粒物提供了重要的保护功能;然而,粘蛋白过度分泌会导致大多数气道疾病的气流阻塞和气道损伤。因此,严格控制粘蛋白的产生和分泌对于气道体内平衡至关重要。气道杯状细胞粘蛋白分泌主要由P2Y2 purinoceptors下游的信号通路控制,尽管其他G蛋白偶联受体和受体酪氨酸激酶也可能起重要作用。气道液层中核苷酸对P2Y2受体的激活导致第二核糖基甘油烯醇(DAG)和钙(Ca2+)的产生,从而导致强大的粘蛋白分泌。值得注意的是,肺中分泌的大多数粘蛋白在基线时连续释放,其调节未知的途径。已知响应激动剂生成的第二个使者的细胞外胞索机械的成分是结合DAG和Ca2+的Munc13启动蛋白,以及结合磷脂磷脂和Ca2+的SNARE触发突触蛋白(SYT)蛋白。我们发现,在气道中表达的两种Munc13蛋白之一Munc13-2的缺失导致小鼠基线和刺激粘蛋白分泌的部分缺陷:因此,该小鼠模型提供了第一个实验工具,可用于解开调节的基线粘蛋白粘蛋白分泌。 Munc13-4,另一种表达的同工型可能调节激动剂刺激粘蛋白分泌。但是,我们的初步数据表明它在基线分泌中可能没有任何作用。相反,缺乏SYT-2会导致刺激分泌的严重缺陷,但我们推断出基线粘蛋白分泌的矛盾增加。其他SYT同工型在小鼠和人类粘液细胞中表达,它们与SYT-2的相互作用可能解释了这些矛盾的结果。我们假设基线和激动剂刺激了粘蛋白的分泌,这是通过气道粘蛋白分泌细胞上游的信号通路和SYT蛋白上游控制的,而特定的Munc13/Syt Pairs Pairs Parairs Partition Basinear和激动剂刺激了粘蛋白分泌。小鼠模型将用于检验该假设,并确定气道粘蛋白分泌调节的确切机制。在特定的目标1中,我们将确定Munc13-2和Munc13-4在体内和体外的气道粘蛋白分泌中的作用,并确定它们如何受到调节以及它们如何对基线和激动剂刺激途径单独贡献。对于特定目标2,我们将确定SYT-2和SYT-7在体内和体外的气道粘蛋白分泌中的作用,确定它们是否以及如何调节它们是否对基线和激动剂刺激的途径有所不同,并确定SYT和MUNC13 ISOFORM之间是否存在显着的功能相互作用。 公共卫生相关性:粘蛋白的过度分泌,导致肺气道中的粘液过度生产,从而大大增加了所有气道疾病的患者发病率和死亡率,常见的疾病(慢性支气管炎和哮喘)和孤儿(孤立的环境)和原发性的环境和基因般的环境和基因般的环境和基因构成。因此,重要的是要了解粘蛋白分泌的分子途径并通过其分泌的分泌,以实现有效的治疗设计和治疗。该项目将使用基因敲除和过表达小鼠模型来揭示两种蛋白质在调节粘蛋白分泌中涉及的蛋白质的作用,即负责启动分泌仪的Munc13和SynaptoTagmin,它们是最终的细胞内钙传感器和分泌物的触发器。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

C. William Davis其他文献

Role of MARCKS in regulated secretion from mast cells and airway goblet cells.
MARCKS 在肥大细胞和气道杯状细胞分泌调节中的作用。
Mechanosensitivity of mouse tracheal ciliary beat frequency: roles for Ca2+, purinergic signaling, tonicity, and viscosity.
小鼠气管纤毛搏动频率的机械敏感性:Ca2+、嘌呤能信号、张力和粘度的作用。

C. William Davis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('C. William Davis', 18)}}的其他基金

Molecular Pathways Regulating Airway Goblet Cell Mucin Secretion
调节气道杯状细胞粘蛋白分泌的分子途径
  • 批准号:
    8217298
  • 财政年份:
    2010
  • 资助金额:
    $ 49.97万
  • 项目类别:
Molecular Pathways Regulating Airway Goblet Cell Mucin Secretion
调节气道杯状细胞粘蛋白分泌的分子途径
  • 批准号:
    7886020
  • 财政年份:
    2010
  • 资助金额:
    $ 49.97万
  • 项目类别:
Molecular Pathways Regulating Airway Goblet Cell Mucin Secretion
调节气道杯状细胞粘蛋白分泌的分子途径
  • 批准号:
    8435548
  • 财政年份:
    2010
  • 资助金额:
    $ 49.97万
  • 项目类别:
Imaging and Histology Core
成像和组织学核心
  • 批准号:
    7688322
  • 财政年份:
    2009
  • 资助金额:
    $ 49.97万
  • 项目类别:
Core--Imaging and Histology
核心——影像与组织学
  • 批准号:
    7410008
  • 财政年份:
    2007
  • 资助金额:
    $ 49.97万
  • 项目类别:
Core--Imaging and Histology
核心——影像与组织学
  • 批准号:
    6774596
  • 财政年份:
    2003
  • 资助金额:
    $ 49.97万
  • 项目类别:
Autocrine regulation of ciliary beat frequency
纤毛跳动频率的自分泌调节
  • 批准号:
    6576228
  • 财政年份:
    2002
  • 资助金额:
    $ 49.97万
  • 项目类别:
Regulation of Airway Goblet Cell Mucin Secretion
气道杯状细胞粘蛋白分泌的调节
  • 批准号:
    7027079
  • 财政年份:
    2000
  • 资助金额:
    $ 49.97万
  • 项目类别:
INTRACELLULAR PATHWAYS MEDIATING AIRWAY MUCIN SECRETION
介导气道粘蛋白分泌的细胞内途径
  • 批准号:
    6027990
  • 财政年份:
    2000
  • 资助金额:
    $ 49.97万
  • 项目类别:
Regulation of Airway Goblet Cell Mucin Secretion
气道杯状细胞粘蛋白分泌的调节
  • 批准号:
    6776225
  • 财政年份:
    2000
  • 资助金额:
    $ 49.97万
  • 项目类别:

相似国自然基金

基于呼吸道菌群失衡介导NLRP3炎症小体激活探讨清肺涤痰治法改善哮喘气道炎症的作用机制
  • 批准号:
    82304934
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
PLZF调控呼吸道合胞病毒感染打破哮喘免疫耐受的研究
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
呼吸中枢驱动在夜间哮喘及睡眠呼吸暂停中的应用价值
  • 批准号:
    82070090
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
IL-36γ通过ILC2细胞对呼吸道感染致哮喘急性加重关键性调控的分子机制研究
  • 批准号:
  • 批准年份:
    2019
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目
钒经PINK1/Parkin通路调控气道上皮细胞线粒体自噬加重过敏性哮喘
  • 批准号:
    31900667
  • 批准年份:
    2019
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Understanding the role of bilevel positive airway pressure (BPAP) in pediatric acute asthma exacerbations: A prospective, randomized, double blind, controlled trial.
了解双水平气道正压通气 (BPAP) 在小儿哮喘急性加重中的作用:一项前瞻性、随机、双盲对照试验。
  • 批准号:
    10448153
  • 财政年份:
    2022
  • 资助金额:
    $ 49.97万
  • 项目类别:
Cholinergic mechanisms involved in transduction of airway defensive reflexes
胆碱能机制参与气道防御反射的转导
  • 批准号:
    10000962
  • 财政年份:
    2019
  • 资助金额:
    $ 49.97万
  • 项目类别:
Cholinergic mechanisms involved in transduction of airway defensive reflexes
胆碱能机制参与气道防御反射的转导
  • 批准号:
    10246173
  • 财政年份:
    2019
  • 资助金额:
    $ 49.97万
  • 项目类别:
Type-2 or Not Type-2: That is the (Therapeutic) Question
Type-2 或非 Type-2:这是(治疗)问题
  • 批准号:
    9405683
  • 财政年份:
    2017
  • 资助金额:
    $ 49.97万
  • 项目类别:
S-nitrosoglutathione reductase and airways hyperreactivity in murine bronchopulmonary dysplasia
S-亚硝基谷胱甘肽还原酶和小鼠支气管肺发育不良中的气道高反应性
  • 批准号:
    9386538
  • 财政年份:
    2017
  • 资助金额:
    $ 49.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了